{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:56:49Z","timestamp":1790708209538,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.jsat.2006.11.009","type":"journal-article","created":{"date-parts":[[2007,1,17]],"date-time":"2007-01-17T07:20:12Z","timestamp":1169018412000},"page":"91-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"title":["Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients"],"prefix":"10.1016","volume":"33","author":[{"given":"Icro","family":"Maremmani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Paolo","family":"Pani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Pacini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Perugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 4","key":"10.1016\/j.jsat.2006.11.009_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0197-2456(89)90058-5","article-title":"Quality of life assessment in clinical trials: Methodologic issues","volume":"10","author":"Aaronson","year":"1989","journal-title":"Controlled Clinical Trials"},{"key":"10.1016\/j.jsat.2006.11.009_bib2","article-title":"Pharmacokinetics of liquid vs tablet buprenorphine","author":"Ajir","year":"1998"},{"key":"10.1016\/j.jsat.2006.11.009_bib3","series-title":"Diagnostic and statistical manual of mental disorders, DSM-IV (4th ed.)","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.jsat.2006.11.009_bib4","first-page":"224","article-title":"The reduction of intravenous heroin use, non-opiate abuse and crime during methadone maintenance treatment: Further findings","volume":"81","author":"Ball","year":"1988","journal-title":"NIDA Research Monograph"},{"key":"10.1016\/j.jsat.2006.11.009_bib5","series-title":"The effectiveness of methadone maintenance treatment","author":"Ball","year":"1991"},{"key":"10.1016\/j.jsat.2006.11.009_bib6","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1046\/j.1360-0443.2001.9656834.x","article-title":"A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence","volume":"96","author":"Barnett","year":"2001","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2006.11.009_bib7","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1037\/0735-7028.8.4.464","article-title":"Quality of life, social indicators and criteria of change","volume":"8","author":"Blau","year":"1977","journal-title":"Professional Psychology"},{"key":"10.1016\/j.jsat.2006.11.009_bib8","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.3109\/10826089409048714","article-title":"A comparison of abstinence-oriented and indefinite methadone maintenance treatment","volume":"29","author":"Caplehorn","year":"1994","journal-title":"International Journal of Addictions"},{"key":"10.1016\/j.jsat.2006.11.009_bib9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1360-0443.1993.tb02769.x","article-title":"Methadone dose and heroin use during maintenance treatment","volume":"88","author":"Caplehorn","year":"1993","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2006.11.009_bib10","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1001\/jama.1989.03430120118033","article-title":"Methadone treatment and acquired immuno-deficiency syndrome","volume":"262","author":"Cooper","year":"1989","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.jsat.2006.11.009_bib11","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1001\/jama.288.7.850","article-title":"Changes in methadone treatment practices: Results from a national panel study, 1988\u20132000","volume":"288","author":"D'Aunno","year":"2002","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.jsat.2006.11.009_bib12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1001\/jama.1992.03480020063032","article-title":"Variations in methadone treatment practices: Results from a national study","volume":"267","author":"D'Aunno","year":"1992","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.jsat.2006.11.009_bib13","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eurpsy.2004.09.002","article-title":"Depressive symptoms during buprenorphine vs. methadone maintenance: Findings from a randomised, controlled trial in opioid dependence","volume":"19","author":"Dean","year":"2004","journal-title":"European Psychiatry"},{"key":"10.1016\/j.jsat.2006.11.009_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bs.3830190102","article-title":"The Hopkins Symptom Checklist (HSCL)\u2014A self-report symptom inventory","volume":"19","author":"Derogatis","year":"1974","journal-title":"Behavioral Science"},{"key":"10.1016\/j.jsat.2006.11.009_bib15","first-page":"2011","article-title":"Rehabilitation of heroin addicts after blockade with methadone","volume":"66","author":"Dole","year":"1966","journal-title":"New York State Medical Journal"},{"key":"10.1016\/j.jsat.2006.11.009_bib16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJM198201213060310","article-title":"Sounding board: Performance-based rating of methadone maintenance programs","volume":"306","author":"Dole","year":"1982","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2006.11.009_bib17","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1093\/clinchem\/43.12.2292","article-title":"Subnanogram-concentration measurement of buprenorphine in human plasma by electron-capture capillary gas chromatography: Application to pharmacokinetics of sublingual buprenorphine","volume":"43","author":"Everhart","year":"1997","journal-title":"Clinical Chemistry"},{"key":"10.1016\/j.jsat.2006.11.009_bib18","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1046\/j.1360-0443.1999.94913376.x","article-title":"Buprenorphine versus methadone maintenance for the treatment of opioid dependence","volume":"94","author":"Fischer","year":"1999","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2006.11.009_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugalcdep.2003.11.017","article-title":"Buprenorphine versus methadone for opioid dependence: Predictor variables for treatment outcome","volume":"75","author":"Gerra","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2006.11.009_bib20","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1100\/tsw.2005.52","article-title":"Sublingual buprenorphine and methadone maintenance treatment: A three-year follow-up of quality of life assessment","volume":"24","author":"Giacomuzzi","year":"2005","journal-title":"Scientific World Journal"},{"key":"10.1016\/j.jsat.2006.11.009_bib21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/10826080500391845","article-title":"Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants","volume":"41","author":"Giacomuzzi","year":"2006","journal-title":"Substance Use and Misuse"},{"key":"10.1016\/j.jsat.2006.11.009_bib22","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1046\/j.1360-0443.2003.00352.x","article-title":"Buprenorphine versus methadone maintenance treatment in an ambulant setting: A health-related quality of life assessment","volume":"98","author":"Giacomuzzi","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2006.11.009_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2165\/00019053-200523010-00007","article-title":"A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting","volume":"23","author":"Harris","year":"2005","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jsat.2006.11.009_bib24","series-title":"Drug abuse treatment: A national study of effectiveness","author":"Hubbard","year":"1989"},{"key":"10.1016\/j.jsat.2006.11.009_bib25","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJM200011023431802","article-title":"A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence","volume":"343","author":"Johnson","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2006.11.009_bib26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0376-8716(95)01189-7","article-title":"Buprenorphine treatment of opioid dependence: Clinical trial of daily vs. alternate-day dosing","volume":"40","author":"Johnson","year":"1995","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2006.11.009_bib27","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1001\/jama.1992.03480200058024","article-title":"A controlled trial of buprenorphine treatment for opioid dependence","volume":"267","author":"Johnson","year":"1992","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.jsat.2006.11.009_bib28","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00005053-199306000-00004","article-title":"Buprenorphine versus methadone maintenance for opioid dependence","volume":"181","author":"Kosten","year":"1993","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1016\/j.jsat.2006.11.009_bib29","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1360-0443.1998.9344753.x","article-title":"Buprenorphine maintenance treatment of opiate dependence: A multicenter randomized clinical trial","volume":"93","author":"Ling","year":"1998","journal-title":"Addiction"},{"issue":"2 Suppl","key":"10.1016\/j.jsat.2006.11.009_bib30","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/S0376-8716(03)00059-0","article-title":"Clinical efficacy of buprenorphine: Comparisons to methadone and placebo","volume":"70","author":"Ling","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2006.11.009_bib31","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/archpsyc.1996.01830050035005","article-title":"A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence","volume":"53","author":"Ling","year":"1996","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2006.11.009_bib32","series-title":"DAH-RS: Drug Addiction History Rating Scale","author":"Maremmani","year":"1989"},{"key":"10.1016\/j.jsat.2006.11.009_bib33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1037\/1064-1297.13.4.293","article-title":"Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence","volume":"13","author":"Marsch","year":"2005","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1016\/j.jsat.2006.11.009_bib34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1360-0443.2003.00335.x","article-title":"Buprenorphine versus methadone maintenance therapy: A randomized double-blind trial with 405 opioid-dependent patients","volume":"98","author":"Mattick","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2006.11.009_bib35","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"3","author":"Mattick","year":"2004","journal-title":"Cochrane Database System Review"},{"key":"10.1016\/j.jsat.2006.11.009_bib36","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1001\/jama.1993.03500150065028","article-title":"The effect of psychosocial services in substance abuse treatment","volume":"269","author":"McLellan","year":"1993","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.jsat.2006.11.009_bib37","unstructured":"Mendelson, J.H., Upton, R., Jones, R.T., & Jacob, P., 1995. Buprenorphine pharmacokinetics: Bioequivalence of an 8 mg sublingual tablet formulation, 1995."},{"key":"10.1016\/j.jsat.2006.11.009_bib38","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0376-8716(00)80006-X","article-title":"Buprenorphine: A controlled clinical trial on the efficacy in the treatment of opioid dependence","volume":"60","author":"Pani","year":"2000","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2006.11.009_bib39","first-page":"33","article-title":"Take-home and compliance with methadone maintenance treatment","volume":"2","author":"Pani","year":"2000","journal-title":"Heroin Addiction and Related Clinical Problems"},{"key":"10.1016\/j.jsat.2006.11.009_bib40","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0376-8716(00)00163-0","article-title":"Double-blind randomized trial of buprenorphine and methadone in opiate dependence","volume":"62","author":"Petitjean","year":"2001","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2006.11.009_bib41","series-title":"Health care technology and its assessment: An international perspective","first-page":"114","article-title":"Health care technology assessment and health related quality of life","author":"Revicki","year":"1993"},{"key":"10.1016\/j.jsat.2006.11.009_bib42","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1023\/A:1008996223999","article-title":"Recommendations on health-related quality of life research to support labelling and promotional claims in the United States","volume":"9","author":"Revicki","year":"2000","journal-title":"Qualitative Life Research"},{"key":"10.1016\/j.jsat.2006.11.009_bib43","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/archpsyc.1982.04290020021004","article-title":"Diagnosis and symptoms of depression in opiate addicts: Course and relationship to treatment outcome","volume":"39","author":"Rounsaville","year":"1982","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2006.11.009_bib44","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00005053-199801000-00006","article-title":"Prognostic factors in buprenorphine- versus methadone-maintained patients","volume":"186","author":"Schottenfeld","year":"1998","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1016\/j.jsat.2006.11.009_bib45","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/archpsyc.1997.01830200041006","article-title":"Buprenorphine vs. methadone maintenance treatment for concurrent opioid dependence and cocaine abuse","volume":"54","author":"Schottenfeld","year":"1997","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2006.11.009_bib46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0376-8716(99)00012-5","article-title":"Pharmacokinetic comparison of the buprenorphine sublingual liquid and tablet","volume":"56","author":"Schuh","year":"1999","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2006.11.009_bib47","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/105504999305695","article-title":"A 12-year follow-up of a methadone medical maintenance program","volume":"8","author":"Schwartz","year":"1999","journal-title":"American Journal on Addictions"},{"key":"10.1016\/j.jsat.2006.11.009_bib48","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1176\/ajp.136.11.1449","article-title":"The relation of time spent in drug abuse treatment to posttreatment outcome","volume":"136","author":"Simpson","year":"1979","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2006.11.009_bib49","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1001\/archpsyc.1981.01780330033003","article-title":"Treatment of drug abuse: Follow-up outcomes and length of time spent","volume":"38","author":"Simpson","year":"1981","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2006.11.009_bib50","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0376-8716(97)00099-9","article-title":"Drug abuse treatment retention and process effects on follow-up outcomes","volume":"47","author":"Simpson","year":"1997","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2006.11.009_bib51","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/jama.281.11.1000","article-title":"Moderate- vs high-dose methadone in the treatment of opioid dependence: A randomized trial","volume":"281","author":"Strain","year":"1999","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.jsat.2006.11.009_bib52","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00005053-199104000-00007","article-title":"Early treatment time course of depressive symptoms in opiate addicts","volume":"179","author":"Strain","year":"1991","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1016\/j.jsat.2006.11.009_bib53","doi-asserted-by":"crossref","first-page":"23","DOI":"10.7326\/0003-4819-119-1-199307010-00004","article-title":"Dose\u2013response effects of methadone in the treatment of opioid dependence","volume":"119","author":"Strain","year":"1993","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jsat.2006.11.009_bib54","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0376-8716(93)90052-R","article-title":"Methadone dose and treatment outcome","volume":"33","author":"Strain","year":"1993","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2006.11.009_bib55","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1176\/ajp.151.7.1025","article-title":"Comparison of buprenorphine and methadone in the treatment of opioid dependence","volume":"151","author":"Strain","year":"1994","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2006.11.009_bib56","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF02247469","article-title":"Buprenorphine versus methadone in the treatment of opioid-dependent cocaine users","volume":"116","author":"Strain","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jsat.2006.11.009_bib57","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00004714-199602000-00010","article-title":"Buprenorphine versus methadone in the treatment of opioid dependence: Self-reports, urinalysis and Addiction Severity Index","volume":"16","author":"Strain","year":"1996","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jsat.2006.11.009_bib58","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0140-6736(05)76462-X","article-title":"Methadone and quality of life","volume":"353","author":"Torrens","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jsat.2006.11.009_bib59","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1360-0443.1997.tb02937.x","article-title":"Use of the Nottingham Health Profile for measuring health status of patients in methadone maintenance treatment","volume":"92","author":"Torrens","year":"1997","journal-title":"Addiction"},{"issue":"Suppl 1","key":"10.1016\/j.jsat.2006.11.009_bib60","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000052036","article-title":"Comparison of buprenorphine and methadone in the treatment of opioid dependence. Swiss multicentre study","volume":"4","author":"Uehlinger","year":"1998","journal-title":"European Addiction Research"},{"key":"10.1016\/j.jsat.2006.11.009_bib61","first-page":"833","article-title":"Drug addiction maintenance treatment and quality of life measurements","volume":"40","author":"Vanagas","year":"2004","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.jsat.2006.11.009_bib62","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1100\/tsw.2003.57","article-title":"Psychoactive drugs and quality of life","volume":"3","author":"Ventegodt","year":"2003","journal-title":"Scientific World Journal"},{"key":"10.1016\/j.jsat.2006.11.009_bib63","series-title":"Assessment of quality of life in clinical trials of cardiovascular therapies","first-page":"87","article-title":"Methodological considerations in the selection of health status assessment procedures","author":"Ware","year":"1984"},{"key":"10.1016\/j.jsat.2006.11.009_bib64","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0899-3289(01)00054-2","article-title":"A meta-analysis comparing the effectiveness of buprenorphine and methadone","volume":"12","author":"West","year":"2000","journal-title":"Journal of Substance Abuse"},{"key":"10.1016\/j.jsat.2006.11.009_bib65","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1046\/j.1360-0443.2000.951217717.x","article-title":"Population-based pharmacokinetic approach for methadone monitoring of opiate addicts: Potential clinical utility","volume":"95","author":"Wolff","year":"2000","journal-title":"Addiction"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547206003692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547206003692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:30:48Z","timestamp":1760038248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547206003692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0740547206003692"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2006.11.009","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2006.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}